Mode of Action ofAntibacterial Agents
Shortly after the introduction of sulphonamides the well-known Woods-Fildes hypothesis was put forward to explain their action. The importance of this was that it not only explained that sulphonamides act by competing with the uptake of the chemically similar para-amino benzoic acid without which the bacterial cell cannot grow, but suggested that the identification of other essential metabolites and synthesis of -their chemical analogues might open the way to innumerable antibacterial agents as successful as sulphonamides. Over the ensuing years there has been little to sustain the high hopes with which this path was originally trodden and it has become apparent that an antibacterial agent which can be successfully used in human therapeutics must have some fairly remarkable properties.
In the first place, many essential metabolic processes are common to widely different species and those which might be accessible to attack in bacteria may well also operate in man. In fact, the process inhibited by sulphonamide is such an example since the ultimate effect of sulphonamide is to deprive the bacterial cell of folates, and these are utilized not only by bacterial but by mammalian cells in the essential synthesis of purines required for the construction of nucleic acids. Some special property must consequently be present either in the system or in the inhibitory agent to cause inhibition of infecting bacteria without a prohibitive degree of accompanying toxicity for the host.
In addition, if an agent is to act competitively with continuing effect against an essential process, it must have a singular affinity for the target enzyme or its competition will be overcome simply by the weight of accumulated natural substrate behind the blocked enzyme. It is too much to hope that there will be many synthetic substances which will prove to have a higher affinity for enzymes than have the natural substrates which the enzymes have evolved specifically to handle. The effect of a successful antibacterial agent must also be such that it is not circumvented by ordinary physiological compensatory or adaptive changes.
Special properties can be seen in the sulphonamides in each of these regards. While folates are essential to both bacteria and man, the means by which they obtain them differ fundamentally. Bacteria synthesize their folate requirement from para-amino benzoate, the supply of which is essential to them. At the same time they (with few exceptions) cannot utilize preformed folates even though they may be available in abundance. Man behaves in precisely the opposite way, obtaining his folates wholly from dietary sources and being incapable of synthesizing them from simple precursors. Thus sulphonamides interfere with a step in folate metabolism which is peculiar to the parasite. It appears also that sulphonamides have a remarkable affinity for the target enzyme and, moreover, evidently are able to switch off the regulatory mechanism through which the enzymic defect produced by sulphonamide could have been recognized and compensated for (Richmond 1966) .
It is through the basic difference in folate metabolism between man and parasite that trimethoprim exerts its potent antibacterial effect. At a stage beyond that blocked by sulphonamide, trimethoprim exerts a still more subtle differential effect on folate supply since the step which is blocked is common to both bacteria and man. Two factors underly its differential effect: trimethoprim has an affinity for the bacterial enzyme 10,000 times greater than that for the mammalian enzyme, and any minor suppression of activity which might occur in the treated host can readily be overcome by feeding folate supplements which cannot be utilized by the bacteria (Hitchings 1961) .
Few other antibacterial agents have had the basis of their selective toxicity so convincingly revealed, but the bacterial cell is evidently open to attack at a variety of loci. Needless to say, any interference with the cell so severe as to prevent its growth or even secure its dissolution must disrupt many processes and it is often difficult to distinguish with certainty the primary event from those which inevitably follow. Primary targets for antibacterial attack range from the genetic core of the cell and essential protein synthesis to the anatomical structures of cell membrane and wall. Examples of the sites at Which some currently useful antibiotics are believed to act are shown in Fig 1. As far as selective toxicity is concerned we may perhaps accept without too much difficulty that interference with the replication of bacterial DNA (such as is believed to result from exposure to nalidixic acid) might be accomplished without similar interference with the host's cells since the DNA of the infecting organisms encompasses the very essence of bacteria-ness.
Several therapeutically important agents act in a way which resenbles that of trimethoprim and sulphonamide in the sense that they interrupt a process which is common to bacterial and mammalian cells: the synthesis of proteins destined to fulfil essential enzymic and structural roles. Despite the basic similarities there are differences between the ribosomes of bacteria and man and it is plain that there will be important differences amongst proteins produced to subserve the purposes of such different creatures.
Much ingenuity (and not a little imagination) has
been used in isolating the precise step in the complex process of protein synthesis which is interrupted by different antibacterial agents.
It currently appears that tetracyclines block the access of amino acids to the ribosomes on which they are strung together into protein, and that chloramphenicol blocks the enzyme which transfers the growing peptide chain to the next amino acid to be added. Fusidic acid and macrolides such as erythromycin apparently block the immediately succeeding step when the messenger RNA (which determines the sequence in which amino acids are linked together) moves in relation to the ribosome so as to indicate which amino acid should next be added. One of the most satisfying explanations of antibiotic action on the ribosome is that suggested by Spotts & Stanier (1961) for streptomycin. Proteins synthesized by bacteria under the influence of streptomycin are defective, but only in the displacement of a single amino acid. It is suggested that attachment of a molecule of steptomycin to the ribosome causes misreading of the instruction given by the messenger RNA so that the wrong amino acid is inserted into the growing peptide chain with the production of functionaly defective protein. One particularly attractive aspect of this hypothesis is that it explains the existence of streptomycin-dependent bacteria (those which will grow only in the presence of streptomycin) as being mutants which naturally misplace an amino acid and can be cured by the misreading resulting from exposure to strtomycin.
Despite the manifest differences which must exist in the production, structure and behaviour el Alcpbr1.p.a- Stereoscan electron micrograph by David Greenwood. x 10,000. (Inpartfrom Garrod & O'Grady 1971) of the proteins of bacteria and man, fundamental similarity in their synthesis is revealed by the fact that in special circumstances potent inhibitors of bacterial protein synthesis may exert a depressant effect on the corresponding processes in man. In patients with severe renal disease, tetracyclines can sufficiently impair the incorporation of amino acids into protein to cause their accumulation, with serious metabolic disturbance. Ribosomes are generated from the cell membrane and it appears that the new-born ones may subserve specialized functions which are peculiarly susceptible to chloramphenicol. Such a special function may be represented in man by the synthesis of antibody which appears to be peculiarly susceptible to chloramphenicol.
In addition to processes which are shared between man and bacteria and which must be subtly distinguished by therapeutically useful compounds, there is an anatomical feature of the bacterial cell which can be viciously attacked without fear of corresponding injury to man since the structure is not present in mammalian cells. This structure, the bacterial cell wall, is chemically extraordinarily complex and its synthesis can be interrupted at a number of points. Cycloserine interferes with the very earliest stage of its assembly in which two molecules of alanine are incorporated into the basic bricks which go to make up the multilayered structure. Penicillin, in contrast, interferes at the other extreme with the process of final cross-linking which gives to the cell wall the extraordinary rigidity which is responsible for the preservation of bacterial shape and for the fact that bacteria will withstand suspension in watera fate which brings about the rapid osmotic destruction of any cell protected only by a membrane. In the process of building the cell wall the components are assembled on lipoprotein carriers and when complete are transferred to the cell-wall skeleton. This transfer is blocked by vancomycin and the process which immediately follows it (the first step in the regeneration of the lipoprotein carrier) is blocked by bacitracin.
This effect of bacitracin is of particular interest since it evidently occurs at the level of the cell membrane (which underlies the cell wall). Other peptide antibiotics, of which the polymyxins are therapeutically the most important, apparently operate at the same level but against Gramnegative rather than the Gram-positive bacteria susceptible to bacitracin. The injuries inflicted on the membrane by peptide antibiotics are usually irreparable and the cells die. In contrast, cells exposed to penicillin (which operates in the wall itself) are left naked but the membrane is uninjured and if mechanical or osmotic damage is avoided the cells survive. Again there are fundamental similarities between different species in their cell-membrane structure and it may be that the effect of polymyxins in producing respiratory and other paralyses in patients with impaired capacity to excrete the drugs represents an effect of polymyxin, corresponding with that on the bacterial cell-membrane, on the lipid-rich membranes of neuronal synapses.
In contrast to the destru'ctive effect of peptides, some agents, notably chloramphenicol, apparently inflict no permanent damage on the bacterial cell and, when the drug is withdrawn, growth is resumed. Despite such obvious differences in overall efict, it is not at prcit pouQiie to identify Wob_I W Usks inevitably lethal. AWaits which opw*t inhibition of protin synthesis rge hu predominatly bacteristatic ci andc tetracyclines to the actively ctericidal strepto mycin. It may be, of course, that destructive effects exerted by such apzts are secondary or independent, but fusidic acid, for examrje,which has so far only been shown to inhibit proein aynthesis, exerts y destructive effecs on staphylococci as revealed by stereoscan electron microscopy (Fig 2) .
In fact, for a number of reasons an absolvAp distinction beween bacteristatic and bactericia agents cannot always be made. In the first plam, a lethal effect may be exerted agaist some organisms (or eve some stains) but not others. Also, even such indisputedly bactericidal agents as penicillin do not extnguish the entire bacterial population. Huge numbers of bacteria are certainly destroyed but some 'persisters' regularly remain. Such survivors which on subsequent regrowth after removal of the agent are still penicillin-sensitive have been explained as a natural consequence of the way in which penicillin exerts its bactericidal effect. Cell-wall synthesis is halted but other metabolic processes go on undisturbed and the cell continues to grow with progressively less cell-wall material available until it becomes unable to withstand the pressure generated by the ingress of water from the environment and like an over-filled balloon explodes. It follows that if the cells are in an environment of suitably high osmolality so that no such osmotic pressure is exerted on the fragile cell membrane, cell-wall-deficient 'spheroplasts' (so called because with their cell wall they lose their natural contours and assume a spherical shape from unimpeded distribution of their contents) will survive and, because they lack cell wall, be insusceptible to further ravages from penicillin. Elegant as this explanation is, it cannot account for the nority population which survives exposure to a great variety of antibacterial agents operating through all sorts of mechanisms.
The observations of several workers, notably Gunnison et al. (1964) and recent studies by Grenwood show that the survival of a minority of still-sensitive organisms in the presence of penicillin cannot be wholly satisfactorily explained by the production of spheroplasts. When escherichia are suitably exposed to penicillins, massive destruction of the bacterial population occurs but a few morphologically nornal cells remain (Greenwood & O'Grady 1969a). It seems likely that such cells owe their survival to a state of suspended animation and might reasonably be supposed to play a part in the regrowth which Fis 3 Growth qfter 48 hours' incu n ofPots mirabiis arownda,wel contain*tna xid acid 500 pg/ml. On sibtulture 'resistant' colonies growing in the zone of nhbition again yelda minority of 'resistant' anda majority ofsensitive colonies occurs on removal of the agent. Perhaps the most striking morphological evidence of such intrapopulation differences in susceptibility to antibacterial agents is provided by the effect of penicillins on streptococci. Within a short length of chain the exposed organisms show cocci which range from the apparently normal to the neardestroyed, the main injury occurring at the interface between dividing cocci where the most active synthesis of fresh cell wall takes place (Greenwood & O'Grady 1969b) . Such intrapopulation differences in susceptibility are by no means peculiar to agents which inhibit bacterial cell-wall synthesis. One of the most striking examples of such differences can be seen with nalidixic acid (Fig 3) which in its inhibition of DNA synthesis might be regarded as operating at the remotest point from the clothing of the cell in its outer coat. As Fig 3 shows , some bacterial cells grew in the presence of the drug to which the bulk of the population was sensitive. When 'resistant' colonieseven those growing immediately adjacent to the antibacterial ag:ntwere used to seed fresh plates containing wells charged with the same concentration of drug as before, exactly the same appearance developed. The bacterial population was evidently 'sensitive' yet some cells exhibited resistance to the agent of a high order, and of a quite different kind from that shown by resistant mutants.
As we examine in more detail the spectrum of responses of large bacterial populations, we are likely to have to think again precisely what we mean by such convenient terms as 'bactericidal'or even, for that matter, 'sensitive'. Dr Naomi Datta (Bacteriology Department, RoyalPostgraduate Medical School, London W12)
Transferable Antibiotic Resistance in Escherichia coli
The R factors found in Escherichia coli are the same as those found in salmonella, shigella and other Gram-negative genera whose habitat is the human or animal intestine. Nearly all naturally occurring drug resistance in E. coli is determined by these factors, which are acquired genetic elements, consisting of DNA. They carry genes determining their own transmissibility, as well as genes determining resistance to important antibacterial drugs. In E. coli, the genetic information for transfer and for resistance seems usually to be linked on a single element which has the properties of an extra chromosome.
The importance of antibiotic resistance in E. coli can be considered first in those serotypes which cause infantile gastroenteritis and secondly in the normal bowel flora.
Infantile Gastroenteritis Enteropathogenic E. coli and the R factors which they often carry have received public attention in the last few years, especially during the outbreaks on Tees-side (1967-8) and in Manchester (1968-9) (British Medical Journal 1968 , 1969 . There was a suggestion that multiple drug resistance, present in the epidemic strains and determined by R factors, led to, or at least was associated with, a high mortality rate. But Dr Joan Taylor in her review of the subject (1970) showed that mortality in infantile gastroenteritis, which was sometimes as high as 50% at the end of the 1940s, dropped steeply in the early 1950s and has remained low ever since, even during the outbreaks which caused such public concern. The extent to which lowered mortality was the result of the introduction of antibiotic treatment cannot be clearly assessed, since great improvements in the control of fluid and electrolyte balance were introduced at the same time. The importance of drug resistance in enteropathogenic E. coli must obviously reflect the importance of antibacterial drugs in treatment.
Normal Intestinal E. coli R factors in the resident E. coli of the bowel may constitute a danger in two ways:
(1) They may be transferred to enteric pathogens. There are plenty of examples of salmonella or shigella acquiring R factors during the course of an infection (e.g. Watanabe 1966 , Datta 1962 , Davies et al. 1968b ).
(2) Normal intestinal bacteria cause parenteral infections. The commonest are those of the urinary tract, but hospital infections of other kinds are also important. R factors in parenteral infections limit, sometimes severely, the choice of treatment.
Increasing Incidence ofResistance R factors have spread in a remarkable way in the last decade in enteric pathogenic bacteria all over the world. They were first discovered in Japan in Shigellaflexneri. In Strong selection for resistance in these bacteria must be exerted by the treatment of diarrhocal disease with antibiotics. One might expect to find a lower incidence of resistance in the normal intestinal bacteria of healthy people. But surveys in London (Datta 1969a, and unpublished observations) show that over 50% of normal people now harbour R+ bacteria and in about 30% of people these represent the predominant strain of resident E. coli. At present the commonest resistances are against streptomycin, the tetracyclines and sulphonamides, but intestinal E. coli resistant to ampicillin, chloramphenicol and neomycin/kanamycin are not rare. Multiple resistance is commoner than single.
Resistance in Hospital
Patients on admission to hospital showed a small but significant tendency to acquire more resistant intestinal E. coli (Datta 1969b) . But the strains isolated after admission had similar resistance patterns to those isolated outside hospital: no characteristically resistant population of 'hospital' coliform bacteria was identified.
